China temporarily includes COVID-19 antigen tests in medical insurance

BEIJING, March 21 (Xinhua) -- China has brought antigen tests into its medical insurance as an interim measure against COVID-19, according to the National Healthcare Security Administration.

Such expenses occurred at designated grassroots medical institutions should be settled pursuant to existing provisions of social pooling units while the cost for antigen testing reagents at designated retail pharmacies can be covered by individual accounts, said the administration in a circular issued on Monday.